Literature DB >> 23464314

Commissioning of the Varian TrueBeam linear accelerator: a multi-institutional study.

C Glide-Hurst1, M Bellon, R Foster, C Altunbas, M Speiser, M Altman, D Westerly, N Wen, B Zhao, M Miften, I J Chetty, T Solberg.   

Abstract

PURPOSE: Latest generation linear accelerators (linacs), i.e., TrueBeam (Varian Medical Systems, Palo Alto, CA) and its stereotactic counterpart, TrueBeam STx, have several unique features, including high-dose-rate flattening-filter-free (FFF) photon modes, reengineered electron modes with new scattering foil geometries, updated imaging hardware/software, and a novel control system. An evaluation of five TrueBeam linacs at three different institutions has been performed and this work reports on the commissioning experience.
METHODS: Acceptance and commissioning data were analyzed for five TrueBeam linacs equipped with 120 leaf (5 mm width) MLCs at three different institutions. Dosimetric data and mechanical parameters were compared. These included measurements of photon beam profiles (6X, 6XFFF, 10X, 10XFFF, 15X), photon and electron percent depth dose (PDD) curves (6, 9, 12 MeV), relative photon output factors (Scp), electron cone factors, mechanical isocenter accuracy, MLC transmission, and dosimetric leaf gap (DLG). End-to-end testing and IMRT commissioning were also conducted.
RESULTS: Gantry/collimator isocentricity measurements were similar (0.27-0.28 mm), with overall couch/gantry/collimator values of 0.46-0.68 mm across the three institutions. Dosimetric data showed good agreement between machines. The average MLC DLGs for 6, 10, and 15 MV photons were 1.33 ± 0.23, 1.57 ± 0.24, and 1.61 ± 0.26 mm, respectively. 6XFFF and 10XFFF modes had average DLGs of 1.16 ± 0.22 and 1.44 ± 0.30 mm, respectively. MLC transmission showed minimal variation across the three institutions, with the standard deviation <0.2% for all linacs. Photon and electron PDDs were comparable for all energies. 6, 10, and 15 MV photon beam quality, %dd(10)x varied less than 0.3% for all linacs. Output factors (Scp) and electron cone factors agreed within 0.27%, on average; largest variations were observed for small field sizes (1.2% coefficient of variation, 10 MV, 2 × 2 cm(2)) and small cone sizes (<1% coefficient of variation, 6 × 6 cm(2) cone), respectively.
CONCLUSIONS: Overall, excellent agreement was observed in TrueBeam commissioning data. This set of multi-institutional data can provide comparison data to others embarking on TrueBeam commissioning, ultimately improving the safety and quality of beam commissioning.

Entities:  

Mesh:

Year:  2013        PMID: 23464314     DOI: 10.1118/1.4790563

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  56 in total

1.  Polarity correction factor for flattening filter free photon beams in several cylindrical ionization chambers.

Authors:  Toshiyuki Ogata; Kazuyuki Uehara; Masao Nakayama; Shinji Tsudou; Takashi Masutani; Takanobu Okayama
Journal:  Radiol Phys Technol       Date:  2016-02-12

2.  Dosimetric accuracy of dynamic couch rotation during volumetric modulated arc therapy (DCR-VMAT) for primary brain tumours.

Authors:  Gregory Smyth; Philip M Evans; Jeffrey C Bamber; Henry C Mandeville; A Rollo Moore; Liam C Welsh; Frank H Saran; James L Bedford
Journal:  Phys Med Biol       Date:  2019-04-05       Impact factor: 3.609

3.  Technical Report: Reference photon dosimetry data for Varian accelerators based on IROC-Houston site visit data.

Authors:  James R Kerns; David S Followill; Jessica Lowenstein; Andrea Molineu; Paola Alvarez; Paige A Taylor; Francesco C Stingo; Stephen F Kry
Journal:  Med Phys       Date:  2016-05       Impact factor: 4.071

4.  Modification and validation of an analytical source model for external beam radiotherapy Monte Carlo dose calculations.

Authors:  Scott E Davidson; Jing Cui; Stephen Kry; Joseph O Deasy; Geoffrey S Ibbott; Milos Vicic; R Allen White; David S Followill
Journal:  Med Phys       Date:  2016-08       Impact factor: 4.071

5.  Beam data modeling of linear accelerators (linacs) through machine learning and its potential applications in fast and robust linac commissioning and quality assurance.

Authors:  Wei Zhao; Ishan Patil; Bin Han; Yong Yang; Lei Xing; Emil Schüler
Journal:  Radiother Oncol       Date:  2020-10-08       Impact factor: 6.280

6.  Evaluation of the Differences Between Measurements in Multiple Institutions and Calculation Modeled by Representative Beam Data in Prostate VMAT Plan.

Authors:  Hironao Goto; Hirokazu Mizuno; Yuichi Akino; Masaru Isono; Yoshihiro Tanaka; Norihisa Masai; Toshijiro Yamamoto; Masahiko Koizumi
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

7.  Assessment with cone-beam computed tomography of intrafractional motion and interfractional position changes of resectable and borderline resectable pancreatic tumours with implanted fiducial marker.

Authors:  Shingo Ohira; Masaru Isono; Yoshihiro Ueda; Takero Hirata; Reiko Ashida; Hidenori Takahashi; Masayoshi Miyazaki; Masaaki Takashina; Masahiko Koizumi; Teruki Teshima
Journal:  Br J Radiol       Date:  2017-03-03       Impact factor: 3.039

8.  Agreement Between Institutional Measurements and Treatment Planning System Calculations for Basic Dosimetric Parameters as Measured by the Imaging and Radiation Oncology Core-Houston.

Authors:  James R Kerns; David S Followill; Jessica Lowenstein; Andrea Molineu; Paola Alvarez; Paige A Taylor; Stephen F Kry
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-04-02       Impact factor: 7.038

9.  Investigating the dosimetric effects of grid size on dose calculation accuracy using volumetric modulated arc therapy in spine stereotactic radiosurgery.

Authors:  Chin Snyder Karen; Manju Liu; Bo Zhao; Yimei Huang; Wen Ning; Indrin J Chetty; M Salim Siddiqui
Journal:  J Radiosurg SBRT       Date:  2017

10.  Commissioning of and preliminary experience with a new fully integrated computed tomography linac.

Authors:  Lei Yu; Jun Zhao; Zhen Zhang; Jiazhou Wang; Weigang Hu
Journal:  J Appl Clin Med Phys       Date:  2021-06-20       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.